Amy C. Moore: Brightest stars of lung cancer research, treatment and advocacy at ILCSC24

The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference designed for people with lung cancer, caregivers, and advocates. This conference offers a unique opportunity to engage with top researchers and hear about the latest advancements in treatments, discover new ways to manage treatment side effects, and find inspiration in today’s scientific progress.

LUNGevity Foundation shared on LinkedIn:

“The world’s leading lung cancer experts are coming to the comfort of your home September 20-21.

Register for the free, virtual International Lung Cancer Survivorship Conference to learn about the latest advances, join breakout discussions, and ask the experts questions.”

Herbert Loong added a comment:

“Looking forward to this truly international lung cancer event!”

Amy C. Moore also added:

“I am SO EXCITED about the program we’ve put together for you this year! We’re bringing the brightest stars of lung cancer research, treatment and advocacy directly to you. Learn the latest advances all from the comfort of home! Best part: it’s FREE. Register today!”

For more events like this, visit oncodaily.com

Dr. Herbert H. F. Loong is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).

Dr. Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science & Research at the Addario Lung Cancer Medical Institute (ALCMI). She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.